Tallac Therapeutics
- Website
- tallactherapeutics.com
- Total Funding
- $182.0M
- Last Round
- $120.0M Series BMay 2024
- Rounds
- 2
About
Biopharmaceutical company developing CpG-Antibody conjugates for cancer immunotherapy
Summary
It has raised $182.0M in total across 2 rounds, most recently a $120.0M Series B round in May 2024. Investors include TCGX, Horizon Technology Finance and venBIO Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
$120.0M
May 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.